Peter Traxler

6.2k total citations · 1 hit paper
61 papers, 4.6k citations indexed

About

Peter Traxler is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Peter Traxler has authored 61 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 28 papers in Oncology and 20 papers in Organic Chemistry. Recurrent topics in Peter Traxler's work include HER2/EGFR in Cancer Research (21 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Microbial Natural Products and Biosynthesis (11 papers). Peter Traxler is often cited by papers focused on HER2/EGFR in Cancer Research (21 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Microbial Natural Products and Biosynthesis (11 papers). Peter Traxler collaborates with scholars based in Switzerland, United States and Austria. Peter Traxler's co-authors include Elisabeth Buchdunger, Pascal Furet, Thomas Meyer, Nicholas Lydon, Pascal Furet, Helmut Mett, Christoph Bock, Johanna Klughammer, Christian Schmidl and Paul Datlinger and has published in prestigious journals such as Journal of Biological Chemistry, Nature Methods and Cancer Research.

In The Last Decade

Peter Traxler

61 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pooled CRISPR screening with single-cell transcriptome readout

2017 655 citations Paul Datlinger, André F. Rendeiro et al. Nature Methods profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Traxler Switzerland	30	2.7k	1.6k	1.1k	465	420	61	4.6k
Alan J. Kraker United States	34	2.7k 1.0×	2.2k 1.4×	1.2k 1.1×	319 0.7×	421 1.0×	46	4.8k
Gordon W. Rewcastle New Zealand	35	2.4k 0.9×	1.2k 0.8×	2.4k 2.1×	350 0.8×	239 0.6×	107	4.7k
Wilbur R. Leopold United States	32	2.9k 1.1×	2.5k 1.6×	1.0k 0.9×	1.1k 2.4×	532 1.3×	65	5.4k
Carolyn Discafani United States	23	1.4k 0.5×	1.4k 0.9×	872 0.8×	569 1.2×	223 0.5×	30	3.0k
Judy Lucas United States	34	2.2k 0.8×	1000 0.6×	1.1k 0.9×	261 0.6×	393 0.9×	69	4.1k
Allan Wissner United States	26	1.9k 0.7×	1.9k 1.2×	1.5k 1.3×	1.1k 2.4×	237 0.6×	64	4.2k
Anne M. Hassell United States	21	1.6k 0.6×	1.0k 0.7×	585 0.5×	331 0.7×	408 1.0×	32	2.9k
Nancy E. Kohl United States	42	5.2k 2.0×	2.4k 1.5×	757 0.7×	511 1.1×	843 2.0×	97	8.0k
Rosanna Supino Italy	37	3.0k 1.1×	1.7k 1.1×	593 0.5×	345 0.7×	803 1.9×	109	4.9k
Steven W. Elmore United States	24	3.2k 1.2×	1.2k 0.8×	716 0.6×	215 0.5×	309 0.7×	37	4.8k

Countries citing papers authored by Peter Traxler

Since Specialization

Citations

This map shows the geographic impact of Peter Traxler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Traxler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Traxler more than expected).

Fields of papers citing papers by Peter Traxler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Traxler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Traxler. The network helps show where Peter Traxler may publish in the future.

Co-authorship network of co-authors of Peter Traxler

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Traxler. A scholar is included among the top collaborators of Peter Traxler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Traxler. Peter Traxler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Traxler, Peter, Lukas Folkman, Lisa E. Shaw, et al.. (2025). Integrated time-series analysis and high-content CRISPR screening delineate the dynamics of macrophage immune regulation. Cell Systems. 16(8). 101346–101346. 1 indexed citations

Datlinger, Paul, André F. Rendeiro, Christian Schmidl, et al.. (2017). Pooled CRISPR screening with single-cell transcriptome readout. Nature Methods. 14(3). 297–301. 655 indexed citations breakdown →

Séquin, Urs, et al.. (2004). Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor. European Journal of Medicinal Chemistry. 39(1). 11–26. 56 indexed citations

Traxler, Peter, Peter R. Allegrini, Ralf Brandt, et al.. (2004). AEE788. Cancer Research. 64(14). 4931–4941. 268 indexed citations

Traxler, Peter. (2003). Tyrosine kinases as targets in cancer therapy – successes and failures. Expert Opinion on Therapeutic Targets. 7(2). 215–234. 187 indexed citations

Traxler, Peter, Guido Bold, Elisabeth Buchdunger, et al.. (2001). Tyrosine kinase inhibitors: From rational design to clinical trials. Medicinal Research Reviews. 21(6). 499–512. 265 indexed citations

Evans, Dean B., Peter Traxler, & Carlos Garcı́a-Echeverrı́a. (2000). Molecular approaches to receptors as targets for drug discovery. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 89. 123–139. 4 indexed citations

Weidner, Stefan, et al.. (1999). Preparation of 4-(4′-Hydroxyanilino)-5-anilinophthalimide and 4,5-Bis-(4′-hydroxyanilino)-phthalimide by Microbial Hydroxylation. Bioscience Biotechnology and Biochemistry. 63(8). 1497–1500. 2 indexed citations

Traxler, Peter & Pascal Furet. (1999). Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors. Pharmacology & Therapeutics. 82(2-3). 195–206. 322 indexed citations

10.

Traxler, Peter. (1998). Tyrosine kinase inhibitors in cancer treatment (Part II). Expert Opinion on Therapeutic Patents. 8(12). 1599–1625. 59 indexed citations

11.

Traxler, Peter. (1997). Protein tyrosine kinase inhibitors in cancer treatment. Expert Opinion on Therapeutic Patents. 7(6). 571–588. 57 indexed citations

12.

Rossé, Gérard, Urs Séquin, Helmut Mett, et al.. (1997). Synthesis of Modified Tripeptides and Tetrapeptides as potential bisubstrate inhibitors of the epidermal growth factor receptor protein tyrosine kinase. Helvetica Chimica Acta. 80(3). 653–670. 10 indexed citations

13.

Corbley, Michael J., Van Cherington, Peter Traxler, Nicholas Lydon, & Thomas M. Roberts. (1996). A strategy for screening anti-tumor drugs utilizing oncogenes encoded in retroviral vectors. International Journal of Cancer. 66(6). 753–759. 2 indexed citations

14.

Buchdunger, Elisabeth, Helmut Mett, Uwe Trinks, et al.. (1995). 4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity.. PubMed. 1(8). 813–21. 24 indexed citations

15.

Furet, Pascal, Giorgio Caravatti, Nicholas Lydon, et al.. (1995). Modelling study of protein kinase inhibitors: Binding mode of staurosporine and origin of the selectivity of CGP 52411. Journal of Computer-Aided Molecular Design. 9(6). 465–472. 87 indexed citations

16.

Traxler, Peter, Uwe Trinks, Elisabeth Buchdunger, et al.. (1995). [(Alkylamino)methyl]acrylophenones: Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase. Journal of Medicinal Chemistry. 38(13). 2441–2448. 72 indexed citations

17.

Gibson, Jerry D., Himanshu V. Kothari, W. Robert Lee, et al.. (1992). Effect of a novel series of macrocyclic hypolipidemic agents on plasma lipid and lipoprotein levels of four non-primate species. Atherosclerosis. 96(2-3). 147–158. 7 indexed citations

18.

Traxler, Peter, Johanna Geissler, W. G. Kump, et al.. (1991). Sulfonylbenzoyl-nitrostyrenes: Potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase. Journal of Medicinal Chemistry. 34(8). 2328–2337. 49 indexed citations

19.

Traxler, Peter, W. TOSCH, & O. Zák. (1987). Papulacandins - Synthesis and biological activity of papulacandin B derivatives.. The Journal of Antibiotics. 40(8). 1146–1164. 24 indexed citations

20.

Traxler, Peter, et al.. (1983). Papulacandins - The relationship between chemical structure and effect on glucan synthesis in yeast.. The Journal of Antibiotics. 36(11). 1539–1542. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact